[The prevention of suppurative-septic complications in severe burns by using immunotropic drug preparations in an experiment].
Pylaeva. S I SI; Gordinskaia. N A NA; Vazina. I R IR; Sidorkin. V G VG; Bushuev. Iu I IuI
Key Findings
- Standard recommended doses of thymalin, myelopid, tactivin, or polyoxydonium showed no benefit in infection control or survival in burned animals.
- A single high‑dose (course) injection of any of these immunomodulators prevented infection generalization.
- Mortality fell dramatically from 80.3% to 47.2% with the high‑dose treatment.
Practical Outcomes
- The data hint that a one‑time higher dose of thymalin might be more effective than routine dosing for severe infection, but the study is limited to animal burns and not directly transferable to humans. Biohackers should treat this as preliminary evidence and not adopt it without further research or clinical validation.
Summary
In a mouse burn‑injury study, giving the immune‑boosting peptide thymalin (and similar compounds) at the normal recommended amount didn’t change infection or survival, but a single larger “course” dose cut the death rate from about 80% to 47% by stopping the infection from spreading.
Abstract
The prophylactic and therapeutic action of immunotropic preparations in different doses on the development of Pseudomonas infection of experimental animals with thermal burns was evaluated. Natural marrow and thymic regulatory peptides (myelopid, tactivin and thymalin), as well as the synthetic immunopreparation polyoxydonium, were used for immunocorrection. The study revealed that the injection of these immunomodulators in doses recommended by instructions for use did not affect the course of the infectious process, antibody production by immunocompetent cells and the death rate of experimental animals. The use of the course dose of any of these substances, introduced in a single injection, prevented the generalization of infection. The death rate of experimental animals dropped from 80.3% to 47.2%.
Study Information
pubmed
2000